INO Financial Facts

Research and development: 26.98M
Loss from operations: -20.2M
See Full Income Statement

Fixed assets, net: 8.99M
Prepaid expenses and other current assets: 1.39M
See Full Balance Sheet

Inovio Pharma (INO) Earnings

  |   Expand Research on INO
Next EPS Date 8/9/22 *Est. EPS Growth Rate N/A
Average EPS % Beat Rate -94.7% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS -14.0% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
5/10/22 Q122 -$0.36-$0.34 -$0.02$199K$670K N/A Details
3/1/22 Q421 -$1.45-$0.32 -$1.13$1.77M$2.84M N/A Details
11/9/21 Q321 N/A-$0.33 N/A N/A$970K N/A N/A N/A
8/9/21 Q221 -$0.39-$0.25 -$0.14$273K$1.21M N/A Details
5/10/21 Q121 N/A-$0.18 N/A N/A$850K N/A N/A N/A
3/1/21 Q420 -$0.14-$0.22 +$0.08$5.6M$1.11M N/A Details
11/9/20 Q320 N/A-$0.19 N/A N/A$3.05M N/A N/A N/A
8/10/20 Q220 -$0.83N/A N/A $237K$135.7K N/A Details